Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
96.25 DKK | -2.58% |
|
-2.58% | -7.45% |
Jun. 19 | Ambu Obtains FDA Clearance For Single-Use Flexible Cysto-Nephroscopy Solution | RE |
Jun. 11 | DNB Carnegie lowers target price for Ambu to DKK 138 (144), reiterates buy recommendation - BN | FW |
Capitalization | 26.32B 4.12B 3.53B 3.29B 3.04B 5.64B 353B 6.28B 39.29B 15B 165B 15.45B 15.14B 603B | P/E ratio 2025 * |
39.5x | P/E ratio 2026 * | 32.1x |
---|---|---|---|---|---|
Enterprise value | 25.87B 4.05B 3.47B 3.23B 2.99B 5.54B 347B 6.17B 38.61B 14.75B 162B 15.19B 14.88B 593B | EV / Sales 2025 * |
4.24x | EV / Sales 2026 * | 3.75x |
Free-Float |
50.22% | Yield 2025 * |
0.66% | Yield 2026 * | 0.77% |
More valuation ratios
* Estimated data
More news
Last Transcript: Ambu A/S
More recommendations
More press releases
More news
1 day | -2.13% | ||
1 week | -3.27% | ||
Current month | -3.17% | ||
1 month | -4.89% | ||
3 months | -18.09% | ||
6 months | -28.73% | ||
Current year | -7.45% |
1 week | 96.25 | ![]() | 99.4 |
1 month | 90.7 | ![]() | 103.9 |
Current year | 90.7 | ![]() | 143.9 |
1 year | 90.7 | ![]() | 154.6 |
3 years | 61.26 | ![]() | 154.6 |
5 years | 61.26 | ![]() | 358.7 |
10 years | 33.2 | ![]() | 358.7 |
Manager | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 2022-05-19 | |
Director of Finance/CFO | 41 | 2023-12-31 | |
Chief Operating Officer | 52 | 2024-06-09 |
Director | Title | Age | Since |
---|---|---|---|
Christian Sagild
BRD | Director/Board Member | 65 | 2011-12-31 |
Jørgen Jensen
CHM | Chairman | 57 | 2020-12-08 |
Susanne Larsson
BRD | Director/Board Member | 57 | 2021-12-13 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
0.12% | 21 M€ | +4.23% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-2.58% | -3.27% | -30.35% | +29.30% | 4.12B | ||
-1.68% | -1.56% | +26.34% | +20.87% | 232B | ||
+0.30% | +2.16% | +14.72% | +0.69% | 115B | ||
-0.78% | -2.34% | +33.07% | +109.04% | 57.63B | ||
-1.45% | +1.25% | -22.15% | -28.14% | 50.87B | ||
+0.34% | +5.38% | -13.57% | +46.23% | 41.62B | ||
-2.60% | +0.54% | -25.98% | +6.32% | 33.51B | ||
+0.49% | -0.22% | -12.76% | +18.09% | 24.66B | ||
-0.97% | -0.10% | +20.93% | -40.66% | 23.39B | ||
-2.05% | -2.89% | +4.01% | +8.36% | 22.7B | ||
Average | -1.05% | -0.39% | -0.57% | +17.01% | 60.55B | |
Weighted average by Cap. | -1.01% | -0.07% | +12.04% | +19.36% |
2025 * | 2026 * | |
---|---|---|
Net sales | 6.1B 955M 817M 761M 704M 1.31B 81.86B 1.45B 9.1B 3.48B 38.25B 3.58B 3.51B 140B | 6.78B 1.06B 909M 847M 783M 1.45B 91.09B 1.62B 10.13B 3.87B 42.56B 3.98B 3.9B 156B |
Net income | 669M 105M 89.66M 83.55M 77.26M 143M 8.99B 160M 999M 382M 4.2B 393M 385M 15.35B | 823M 129M 110M 103M 95M 176M 11.05B 196M 1.23B 469M 5.16B 483M 473M 18.87B |
Net Debt | -453M -70.9M -60.67M -56.53M -52.28M -97.03M -6.08B -108M -676M -258M -2.84B -266M -260M -10.38B | -847M -133M -114M -106M -97.81M -182M -11.38B -202M -1.26B -483M -5.32B -498M -487M -19.43B |
More financial data
* Estimated data
Employees
5,000
Calendar
Aug. 21
- Q3 2025 Earnings Release
Date | Price | Change | Volume |
---|---|---|---|
25-07-11 | 96.25 kr | -2.58% | 324,468 |
25-07-10 | 98.80 kr | +1.44% | 340,928 |
25-07-09 | 97.40 kr | -0.66% | 344,181 |
25-07-08 | 98.05 kr | +0.26% | 312,612 |
25-07-07 | 97.80 kr | -1.71% | 455,608 |
Delayed Quote Nasdaq Copenhagen, July 11, 2025 at 11:20 am EDT
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
98.80DKK
Average target price
130.70DKK
Spread / Average Target
+32.29%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AMBU B Stock
Select your edition
All financial news and data tailored to specific country editions